Home › Post-COVID Conditions (Long COVID) › Arizona
Post-COVID Conditions (Long COVID) clinical trials in Arizona
4 studies for Post-COVID Conditions (Long COVID) are looking for participants at sites in Arizona.
Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen
- Research Site, Tucson
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 2, 2026 · NCT05624450Randomized Double-Blind Placebo-Controlled Trial EValuating Baricitinib on PERSistent NEurologic and Cardiopulmonary Symptoms of Long COVID
- University of Arizona, Tucson
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT06631287A Clinical Study of Molnupiravir to Prevent Severe Illness From Coronavirus Disease 2019 (COVID-19) in People Who Are High Risk (MK-4482-023)
- Helios Clinical Research ( Site 3826), Paradise Valley
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 24, 2026 · NCT06667700Non-invasive Treatment for Long COVID (Post COVID-19 Condition) Brain Fog
- Mayo Clinic in Arizona, Scottsdale
Recruiting
Ages 18 and older · All sexes · Updated Jun 5, 2026 · NCT06614309From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.